Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Day

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Seminars in Diagnostic Pathology|December 9, 1998
Diagnosis and interpretation of steatosis and steatohepatitisA D Burt, A Mutton, C P Day
Journal of Hepatology|December 29, 2000
Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactionsG P Aithal, M D Rawlins, C P Day
British Heart Journal|January 1, 1992
QT dispersion in sinus beats and ventricular extrasystoles in normal heartsC P Day, J M McComb, R W Campbell
BMJ (Clinical Research Ed.)|December 11, 1999
Accuracy of hepatic adverse drug reaction reporting in one English health regionG P Aithal, M D Rawlins, C P Day
British Heart Journal|June 1, 1990
QT dispersion: an indication of arrhythmia risk in patients with long QT intervalsC P Day, J M McComb, R W Campbell
Hepatology (Baltimore, Md.)|April 27, 1999
Inhibition of rat hepatocyte proliferation by transforming growth factor beta and glucagon is associated with inhibition of ERK2 and p70 S6 kinaseM Dixon, L Agius, S J Yeaman, et al.
European Heart Journal|March 1, 1991
Reduction in QT dispersion by sotalol following myocardial infarctionC P Day, J M McComb, J Matthews, et al.
Hepatology (Baltimore, Md.)|July 1, 1997
Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitisJ Grove, A K Daly, M F Bassendine, et al.
Biochemical and Biophysical Research Communications|January 13, 1997
Transforming growth factor beta increases the activity of phosphatidate phosphohydrolase-1 in rat hepatocytesM C Dixon, S J Yeaman, L Agius, et al.
Journal of Hepatology|November 1, 1996
Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosisH L Reeves, A D Burt, S Wood, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Seminars in Diagnostic Pathology|December 9, 1998
Diagnosis and interpretation of steatosis and steatohepatitisA D Burt, A Mutton, C P Day
Journal of Hepatology|December 29, 2000
Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactionsG P Aithal, M D Rawlins, C P Day
British Heart Journal|January 1, 1992
QT dispersion in sinus beats and ventricular extrasystoles in normal heartsC P Day, J M McComb, R W Campbell
BMJ (Clinical Research Ed.)|December 11, 1999
Accuracy of hepatic adverse drug reaction reporting in one English health regionG P Aithal, M D Rawlins, C P Day
British Heart Journal|June 1, 1990
QT dispersion: an indication of arrhythmia risk in patients with long QT intervalsC P Day, J M McComb, R W Campbell
Hepatology (Baltimore, Md.)|April 27, 1999
Inhibition of rat hepatocyte proliferation by transforming growth factor beta and glucagon is associated with inhibition of ERK2 and p70 S6 kinaseM Dixon, L Agius, S J Yeaman, et al.
European Heart Journal|March 1, 1991
Reduction in QT dispersion by sotalol following myocardial infarctionC P Day, J M McComb, J Matthews, et al.
Hepatology (Baltimore, Md.)|July 1, 1997
Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitisJ Grove, A K Daly, M F Bassendine, et al.
Biochemical and Biophysical Research Communications|January 13, 1997
Transforming growth factor beta increases the activity of phosphatidate phosphohydrolase-1 in rat hepatocytesM C Dixon, S J Yeaman, L Agius, et al.
Journal of Hepatology|November 1, 1996
Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosisH L Reeves, A D Burt, S Wood, et al.
Pageof 9